DK2968352T3 - Derivatiserede 3-styryl-cephalosporiner - Google Patents

Derivatiserede 3-styryl-cephalosporiner Download PDF

Info

Publication number
DK2968352T3
DK2968352T3 DK14778768.3T DK14778768T DK2968352T3 DK 2968352 T3 DK2968352 T3 DK 2968352T3 DK 14778768 T DK14778768 T DK 14778768T DK 2968352 T3 DK2968352 T3 DK 2968352T3
Authority
DK
Denmark
Prior art keywords
cephalosporines
styryl
derivatized
Prior art date
Application number
DK14778768.3T
Other languages
Danish (da)
English (en)
Inventor
Larry D Sutton
Sophia Yu
Original Assignee
Gladius Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gladius Pharmaceuticals Corp filed Critical Gladius Pharmaceuticals Corp
Application granted granted Critical
Publication of DK2968352T3 publication Critical patent/DK2968352T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK14778768.3T 2013-03-12 2014-03-12 Derivatiserede 3-styryl-cephalosporiner DK2968352T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361778378P 2013-03-12 2013-03-12
PCT/US2014/024503 WO2014165126A2 (en) 2013-03-12 2014-03-12 Derivatized 3-styryl-cephalosporins

Publications (1)

Publication Number Publication Date
DK2968352T3 true DK2968352T3 (da) 2019-01-02

Family

ID=51659318

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14778768.3T DK2968352T3 (da) 2013-03-12 2014-03-12 Derivatiserede 3-styryl-cephalosporiner

Country Status (7)

Country Link
US (2) US9975905B2 (enExample)
EP (2) EP2968352B1 (enExample)
JP (2) JP6403289B2 (enExample)
CA (1) CA2905240A1 (enExample)
DK (1) DK2968352T3 (enExample)
ES (1) ES2700575T3 (enExample)
WO (1) WO2014165126A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009049086A1 (en) 2007-10-09 2009-04-16 Larry Sutton Broad spectrum beta-lactamase inhibitors
ES2700575T3 (es) * 2013-03-12 2019-02-18 Gladius Pharmaceuticals Corp 3-Estiril-cefalosporinas derivadas
EP3131497B1 (en) 2014-04-16 2023-08-16 ViaCyte, Inc. Instruments for use with implantable encapsulation devices
WO2019070973A1 (en) * 2017-10-04 2019-04-11 Gladius Pharmaceuticals Corporation CEPHAM COMPOUNDS HAVING LATENT REACTIVE GROUPS
EP3521269A1 (en) 2018-02-06 2019-08-07 Clariant Plastics & Coatings Ltd Process for preparation of 1-nitrobenzene-2-alkyloxycarbonyl-5-carboxylic acid
WO2020071314A1 (ja) 2018-10-03 2020-04-09 住友重機械工業株式会社 ショベル

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971778A (en) 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4065620A (en) 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
BE789817A (fr) 1971-10-07 1973-04-06 Glaxo Lab Ltd Perfectionnements aux composes de cephalosporine
US3947413A (en) 1972-11-13 1976-03-30 Merck & Co., Inc. 3-α-Substituted cephalosporins
AR207960A1 (es) 1973-10-03 1976-11-22 Fujisawa Pharmaceutical Co Procedimiento para preparar un acido 7-(acetamido-2-sustituido)-3-cefem-4-carboxilico y sus sales
US4144393A (en) 1973-12-21 1979-03-13 Glaxo Laboratories Limited 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group
CA1136132A (en) 1975-02-17 1982-11-23 Teruji Tsuji Cyclization to form cephem ring and intermediates therefor
US3983113A (en) 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials
DE2760123C2 (de) 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4094978A (en) 1976-07-29 1978-06-13 Syntex (U.S.A.) Inc. 3-propenyl derivatives of cephalosporin, compositions and their use
JPS6011713B2 (ja) 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
US4500457A (en) 1977-05-09 1985-02-19 Ciba-Geigy Corporation Process for preparing thia-aza compounds with a beta-lactam ring
US4255423A (en) 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
EP0042026B1 (de) 1978-02-02 1986-01-08 Ciba-Geigy Ag 3,4-Disubstituierte Azetidin-2-onverbindungen und Verfahren zu ihrer Herstellung
FR2474504A1 (fr) 1979-05-23 1981-07-31 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
ES491686A0 (es) 1979-05-23 1980-12-16 Rhone Poulenc Ind Procedimiento para la obtencion de tiovinil-3 cefalosporinas
FR2457297A1 (fr) 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
FR2457296A1 (fr) 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
US4388326A (en) 1979-08-15 1983-06-14 Merck & Co., Inc. Phenyl hydroxypropyl sulfoxide enzyme inhibitors
PT71654B (en) 1979-08-15 1982-01-22 Merck & Co Inc Process for preparing allylsulfoxide enzyme inhibitor
US4760067A (en) 1979-08-15 1988-07-26 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4342758A (en) 1979-08-15 1982-08-03 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4654359A (en) 1979-08-15 1987-03-31 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4558071A (en) 1979-08-15 1985-12-10 Merck & Co., Inc. Phenyl, trihalomethyl or heteroaryl sulfoxides having a latent allyl group bound to sulfur as enzyme inhibitors
NL8100539A (nl) 1980-02-12 1981-09-01 Rhone Poulenc Ind Nieuwe thiolesters, de bereiding daarvan en hun gebruik bij syntheses.
FR2494280A1 (fr) 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
US4380512A (en) 1980-12-11 1983-04-19 Bristol-Myers Company 2β-Chloromethyl-2α-methylpenam-3α-carboxylic acid sulfone and salts and esters thereof
US4546101A (en) 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
GB8301694D0 (en) 1983-01-21 1983-02-23 Beecham Group Plc Beta-lactam antibacterial agents
US4520022A (en) 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
US4855420A (en) 1983-06-03 1989-08-08 Ici Pharma Cephalosporin derivatives
EP0133670A3 (de) 1983-08-09 1985-12-18 Bayer Ag Verfahren zur Herstellung von 7-Acylamino-3-hydrocy-cephem-4-carbonsäuren und 7-Acylamino-3-hydroxy-1-de-thia-1-oxacephem-4-carbonsäuren
IE58487B1 (en) 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
JPS61178991A (ja) 1984-09-07 1986-08-11 Meiji Seika Kaisha Ltd 新規セフアロスポリン化合物
US4874856A (en) 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
US4692517A (en) 1986-03-20 1987-09-08 American Home Products Corporation C-3' acylaminooxy-7-[(2-aminothiazol-4-yl)-α-(substituted-oximino)acetyl]cephalosporin derivatives
US4870168A (en) 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
JPS63211286A (ja) 1987-02-27 1988-09-02 Sagami Chem Res Center β−ラクタム誘導体
US5171854A (en) 1987-05-26 1992-12-15 Bayer Aktiengesellschaft Substituted vinylcephalosporins
DE3734004A1 (de) 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3734005A1 (de) 1987-05-26 1988-12-15 Bayer Ag Substituierte vinylcephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5073551A (en) 1988-03-30 1991-12-17 Sagami Chemical Research Center Cephalosporin compounds
US5336768A (en) 1988-05-24 1994-08-09 Hoffmann-La Roche Inc. Antibacterial cephalosporin compounds
JPH0686463B2 (ja) 1988-07-01 1994-11-02 明治製菓株式会社 新規セフェム化合物、その製造法及び抗菌剤
JPH0635464B2 (ja) 1988-09-02 1994-05-11 明治製菓株式会社 新規セフェム化合物、その製造法及び抗菌剤
JP2834771B2 (ja) 1989-06-02 1998-12-14 エーザイ株式会社 チアゾリルアセトアミドセフェム誘導体
IL94946A0 (en) 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
US5373001A (en) 1990-06-15 1994-12-13 Roussel Uclaf Cephalosporins
US5397779A (en) 1990-06-15 1995-03-14 Roussel-Uclaf Cephalosporins
DE4030706A1 (de) * 1990-09-28 1992-04-02 Bayer Ag Neue 3-substituierte cephalosporine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US6248881B1 (en) 1991-03-08 2001-06-19 Biochemie Gmbh Intermediates and process for the production of 3-vinyl cephalosporins
EP0503453B1 (en) 1991-03-08 2001-05-09 Biochemie Gesellschaft M.B.H. New process for the production of cephalosporines and novel intermediates in this process
EP0544166A3 (en) 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
EP0592677B1 (en) 1992-02-18 2001-11-07 Otsuka Kagaku Kabushiki Kaisha Beta-LACTAM COMPOUND AND CEPHEM COMPOUND, AND PRODUCTION THEREOF
JP3224279B2 (ja) 1992-07-27 2001-10-29 大塚化学株式会社 セフエム化合物の製造法
JPH06145176A (ja) 1992-11-10 1994-05-24 Kyoto Yakuhin Kogyo Kk セファロスポリン化合物、その製造法および中間体化合物
AU6291194A (en) 1993-03-26 1994-10-24 Yamanouchi Pharmaceutical Co., Ltd. Cephalosporin derivative
JPH06345775A (ja) 1993-06-04 1994-12-20 Kyoto Yakuhin Kogyo Kk セファロスポリン化合物、その製造法および中間体化合物
KR100257130B1 (ko) 1993-09-11 2000-05-15 성재갑 신규 세팔로스포린계 항생제 및 이의 제조방법
US5854227A (en) 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
JPH093074A (ja) 1995-06-20 1997-01-07 Kyoto Yakuhin Kogyo Kk セファロスポリン化合物、その用途および中間体化合物
AT403375B (de) 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
JP4157177B2 (ja) 1997-06-04 2008-09-24 大塚化学ホールディングス株式会社 ３−アルケニルセフェム化合物の製造法
BR0013366A (pt) 1999-08-16 2002-07-23 Revaax Pharmaceuticals Llc Métodos para tratar um distúrbio comportamental, um paciente humano, doença de próstata, distúrbios de ansiedade e cognitivos em um paciente humano afligido com uma condição ou disposto ao desenvolvimento de uma condição distinguida pelo menos em parte pela concentração de glutamato extracelular anormal no cérebro ou em outro tecido nervoso, distúrbio comportamental nas espécies humana, canina, felina e equina e um paciente afligido com ou disposto a desenvolver uma doença compreendendo concentrações de glutamato anormalmente elevadas em tecido neuronal ou nìveis de naaladase elevados em tecido prostático e com esclerose múltipla e para realçar a função cognitiva, formulação farmacêutica e usos de um inibidor da atividade de peptidase de uma dipeptidase ácida ligada em alfa n-acetilada e de um composto de beta-lactama
JP4510957B2 (ja) 1999-09-01 2010-07-28 大塚化学株式会社 セフェム化合物の製造方法
ATE347558T1 (de) 2000-09-22 2006-12-15 Zenyaku Kogyo Kk Cephem verbindungen und diese enthaltende esbl nachweisreagenzien
AU2004256841A1 (en) 2003-06-10 2005-01-20 Fulcrum Pharmaceuticals, Inc. Beta-lactamase inhibitors and methods of use thereof
WO2009049086A1 (en) * 2007-10-09 2009-04-16 Larry Sutton Broad spectrum beta-lactamase inhibitors
US7754134B2 (en) 2007-11-08 2010-07-13 Wagner Michael S Injection molding process
US20100231700A1 (en) 2009-03-10 2010-09-16 Lsi Industries, Inc. 3d screen with modular polarized pixels
WO2010118361A1 (en) 2009-04-09 2010-10-14 Sopharmia, Inc. Beta lactamase inhibitors
ES2700575T3 (es) * 2013-03-12 2019-02-18 Gladius Pharmaceuticals Corp 3-Estiril-cefalosporinas derivadas

Also Published As

Publication number Publication date
JP6403289B2 (ja) 2018-10-10
US9975905B2 (en) 2018-05-22
WO2014165126A2 (en) 2014-10-09
US20160031906A1 (en) 2016-02-04
EP2968352B1 (en) 2018-09-26
WO2014165126A3 (en) 2015-11-05
EP3441071A1 (en) 2019-02-13
US20180319817A1 (en) 2018-11-08
EP2968352A2 (en) 2016-01-20
CA2905240A1 (en) 2014-10-09
EP2968352A4 (en) 2016-09-07
ES2700575T3 (es) 2019-02-18
JP2018188454A (ja) 2018-11-29
JP2016512541A (ja) 2016-04-28
US11028103B2 (en) 2021-06-08
HK1220377A1 (en) 2017-05-05

Similar Documents

Publication Publication Date Title
DK3342773T3 (da) Syk-hæmmere
DK3613453T3 (da) Fordamper
DK3077047T3 (da) Aramcholsalte
DK3052081T3 (da) Pastil
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK2956698T3 (da) Bindestrimler
DK2946640T3 (da) Langmuir-probe
EP2943489A4 (en) DEUTERATED MOMELOTINIB
DE102013106534B8 (de) Chromatographiepipettenspitze
EP2991647A4 (en) DEUTERED AMLEXANOX
DK2968352T3 (da) Derivatiserede 3-styryl-cephalosporiner
EP2970310A4 (en) 5-BROMO-indirubins
EP2853297A4 (en) kendama
DK3071227T3 (da) Fiskevaccine
DE112014001252A5 (de) Aufbissschiene
DK3086679T3 (da) Sportssko
DK2981168T3 (da) Laminitiskile
FI10343U1 (fi) Mittateippi
FI10138U1 (fi) Kelkkateltta
ES1078715Y (es) Mosquitera
DE112014005422A5 (de) Friktionsfalschdrallaggregat
BR112016000501A2 (pt) Nalador
ES1100380Y (es) Trompo
ES1093505Y (es) Aerociclo